Nuclear Medicine Isotopes Market

Global Nuclear Medicine Isotopes Market Size, Share & Trends Analysis Report by Type (Stable Isotopes and Radio Isotopes), By Application (Nuclear Therapy, Equipment Radioactive Source, and Diagnosis) and Forecast (2020-2026)

Published: Oct 2021 | Report Code: OMR2024332 | Category : Pharmaceuticals | Delivery Format: /

The global nuclear medicine isotopes market is estimated to grow at a significant CAGR during the forecast period. Nuclear medicine is used to diagnose and test the effect of a wide range of diseases, including heart diseases, tumors, gastrointestinal, neurological disorders, and endocrine disorders, as well as other abnormalities in the body.

Nuclear medicine isotopes can be used to treat a variety of medical diseases, including cancer, by weakening or destroying certain targeted cells. Positron emission tomography (PET) is a precise method that uses isotopes created in a cyclotron. With fluorine-18 as the tracer, it is widely used in oncology and has been proved to be the most accurate non-invasive technique for detecting and evaluating most cancers. Targeted alpha therapy (TAT) or alpha radio-immunotherapy is an emerging field in cancer treatment, particularly for the control of dispersed tumors. Nuclear medicine is beneficial in oncology in a variety of functions across the course of the disease. Some new approvals of isotopes have been witnessed. For instance, in January 2021, the United States Food and Drug Administration (US FDA) has approved NorthStar Medical Radioisotopes, LLC's production of Mo-99 from concentrated Mo-98 (CMO-98) and relevant software upgrades for the RadioGenix System (technetium Tc 99m generator). 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered 

o By Type

o By Application

  • Region Covered

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape- Bayer AG, General Electric Co., Siemens Healthcare, Cardinal Health, Inc., and Nordion Inc.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Nuclear Medicine Isotopes Market Segmentation

  • By Type

o Stable Isotopes

o Radio Isotopes

  • By Application

o Nuclear Therapy 

o Equipment Radioactive Source

o Diagnosis

Global Nuclear Medicine Isotopes Market is Segmented by Region 

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa

REQUEST FOR TABLE OF CONTENT